Cargando…

Editorial: Immunotherapy for Tumor in the Brain: Insights From—and For—Other Tumor Sites

Detalles Bibliográficos
Autor principal:	Lampson, Lois A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934480/ https://www.ncbi.nlm.nih.gov/pubmed/29755955 http://dx.doi.org/10.3389/fonc.2018.00128

Ejemplares similares

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
por: Dutoit, Valérie, et al.
Publicado: (2016)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
por: Seiffert, Martina, et al.
Publicado: (2022)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
por: Yang, Jieying, et al.
Publicado: (2023)

Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
por: Sureban, Sripathi M., et al.
Publicado: (2022)

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
por: Dastmalchi, Farhad, et al.
Publicado: (2021)

Editorial: Awake surgery for brain tumors and brain connectomics
por: Montemurro, Nicola, et al.
Publicado: (2022)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
por: Wang, Peipei, et al.
Publicado: (2021)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
por: Filley, Anna C., et al.
Publicado: (2018)

Immunotherapy – Strategies for Expanding Its Role in the Treatment of All Major Tumor Sites
por: Sanghera, Chandan, et al.
Publicado: (2019)

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy
por: Yin, Xiaoran, et al.
Publicado: (2023)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
por: Saida, Yu, et al.
Publicado: (2023)

Editorial: GBM stem cells and the brain tumor microenvironment
por: Li, Yunqing, et al.
Publicado: (2023)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Immunotherapy associated central nervous system complications in primary brain tumors
por: Mantica, Megan, et al.
Publicado: (2023)

Emerging Insights into Barriers to Effective Brain Tumor Therapeutics
por: Woodworth, Graeme F., et al.
Publicado: (2014)

Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors
por: Feng, Weijun, et al.
Publicado: (2022)

Editorial: New Insights Into the Landscape of Rare Tumors: Translational and Clinical Research Perspective
por: De Vita, Alessandro, et al.
Publicado: (2020)

Editorial: Exploring the breast tumor microenvironment: Association to metastasis, novel risk factors and novel treatments and immunotherapies
por: Nava-Castro, Karen Elizabeth, et al.
Publicado: (2022)

Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma
por: Li, Xiang, et al.
Publicado: (2021)

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023)

Editorial: Angiogenesis and tumor metastasis
por: Zhang, Qiang-Zhe, et al.
Publicado: (2023)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

Editorial: Intraoperative Ultrasound in Brain Tumor Surgery: State-Of-The-Art and Future Perspectives
por: Del Bene, Massimiliano, et al.
Publicado: (2021)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling
por: Paggetti, Jérôme, et al.
Publicado: (2021)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Taming Tumor Glycolysis and Potential Implications for Immunotherapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Tumor response assessment on imaging following immunotherapy
por: Berz, Antonia M., et al.
Publicado: (2022)

Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023)

Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases
por: Khan, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_na5oq7phd5n3mhaqu8f66hnjtb